A Single-Center, Open-Label, Randomized Study of the Pharmacokinetics of AzaSite [azithromycin] Ophthalmic Solution Versus Vigamox [moxifloxacin] in the Conjunctiva of Healthy Volunteers Following a Single Ocular Administration.

Trial Profile

A Single-Center, Open-Label, Randomized Study of the Pharmacokinetics of AzaSite [azithromycin] Ophthalmic Solution Versus Vigamox [moxifloxacin] in the Conjunctiva of Healthy Volunteers Following a Single Ocular Administration.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Sep 2011

At a glance

  • Drugs Azithromycin; Moxifloxacin
  • Indications Bacterial infections
  • Focus Pharmacokinetics
  • Sponsors Inspire Pharmaceuticals
  • Most Recent Events

    • 27 Jul 2011 Company added as trial sponsor as reported by ClinicalTrials.gov.
    • 27 Feb 2009 Results were published in Clinical Therapeutics in November 2008.
    • 11 Jan 2008 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top